APA (7th ed.) Citation

Jing Wang, Qin Chen, Xinyue Wang, Dingzhi Huang, & Richeng Jiang. (2023). Bevacizumab/PD-1 inhibitor plus chemotherapy as first-line treatment of advanced non-squamous non-small-cell lung cancer. Becaris Publishing Limited.

Chicago Style (17th ed.) Citation

Jing Wang, Qin Chen, Xinyue Wang, Dingzhi Huang, and Richeng Jiang. Bevacizumab/PD-1 Inhibitor Plus Chemotherapy as First-line Treatment of Advanced Non-squamous Non-small-cell Lung Cancer. Becaris Publishing Limited, 2023.

MLA (9th ed.) Citation

Jing Wang, et al. Bevacizumab/PD-1 Inhibitor Plus Chemotherapy as First-line Treatment of Advanced Non-squamous Non-small-cell Lung Cancer. Becaris Publishing Limited, 2023.